Therapeutic efficacy of 5-alkylresorcinol on progression of colorectal cancer by activating HCLS1 and suppressing TLR4/MYD88/NF-κB signaling.

Eur J Med Res · 2025 · PMC12175410 · PMID 40533777

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

an increasing trendp < 0.1so close (0.05 < p ≤ 0.1)

The 5ARs + OE + HCLS1 group showed a further decrease in cell viability ( p < 0.01), while the 5ARs + sh-HCLS1 group exhibited an increasing trend in cell viability ( p < 0.1) (Fig. 4 A, B).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.